Geneos Wealth Management’s Sensient Technologies SXT Stock Holding History

Geneos Wealth Management’s Portfolio SXT Stock Details SXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-42	Closed	-$4.14K	–	3110
2025 Q2	$4.14K	Buy	+42	New	+$3.76K	﹤0.01%	2626
2020 Q1	–	Sell	-542	Closed	-$35K	–	2599
2019 Q4	$35K	Hold	542	–	–	﹤0.01%	1442
2019 Q3	$36K	Hold	542	–	–	﹤0.01%	1342
2019 Q2	$39K	Hold	542	–	–	﹤0.01%	1320
2019 Q1	$36K	Hold	542	–	–	﹤0.01%	1310
2018 Q4	$30K	Hold	542	–	–	﹤0.01%	1333
2018 Q3	$41K	Hold	542	–	–	﹤0.01%	1267
2018 Q2	$38K	Hold	542	–	–	﹤0.01%	1180
2018 Q1	$38K	Hold	542	–	–	﹤0.01%	1130
2017 Q4	$39K	Hold	542	–	–	﹤0.01%	1118
2017 Q3	$41K	Hold	542	–	–	﹤0.01%	1057
2017 Q2	$43K	Hold	542	–	–	﹤0.01%	987
2017 Q1	$42K	Sell	542 -13	-2%	-$1.02K	﹤0.01%	957
2016 Q4	$43K	Hold	555	–	–	0.01%	897
2016 Q3	$42K	Buy	555 +13	+2%	+$954	0.01%	882
2016 Q2	$38K	Hold	542	–	–	0.01%	903
2016 Q1	$34K	Buy	+542	New	+$31.9K	0.01%	924

Other funds holding SXT

Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Geneos Wealth Management's SXT Position: Q3 2025 in Review

Geneos Wealth Management sold out of Sensient Technologies (SXT) in Q3 2025, closing a stake of 42 shares — an estimated $4.14K sold.

Geneos Wealth Management first reported a position in SXT in Q1 2016 and held it in 17 quarters. The position peaked at $43K in Q2 2017. 328 funds tracked by Wall St. Rank hold SXT as of Q3 2025.

Geneos Wealth Management reported no remaining Sensient Technologies position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 42 Sensient Technologies shares in Q3 2025, an estimated $4.14K.
Geneos Wealth Management first reported a position in Sensient Technologies in Q1 2016 and held it in 17 quarters.
Geneos Wealth Management's Sensient Technologies position peaked at $43K in Q2 2017.
328 funds tracked by Wall St. Rank held Sensient Technologies as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.